经内镜鼻胆管引流术胆管冷却保护技术在肝癌微波消融中的应用被引量：7

Application of ENBD tube intraductal cooling technique to percutaneous microwave ablation for hepatocellular carcinomas

原文传递

导出

摘要目的探讨经内镜鼻胆管引流术（endoscopic nasobiliary drainage，ENBD）灌注冷却液在近肝门部肝癌经皮微波消融（percutaneous microwave ablation，PMWA）中防止胆管热损伤的作用。方法2013年9月至2015年5月，前瞻性纳入20例因近肝门部肝癌行经皮肝穿刺肝癌微波消融的患者。共20个病灶靠近肝门部主胆管，先经ERCP留置ENBD管于肿瘤旁胆管，向ENBD管内快速持续灌注4℃生理盐水，再在超声引导下行PMWA治疗。术后观察是否有胆管热损伤并发症及肝癌原位复发情况。结果平均随访8．0个月，20例患者均无手术相关性死亡，其中19例（95％）患者无胆管热损伤，1例（5％）患者出现术后胆汁瘤；2例（10％）患者ERCP乳头切开后出血，3例（15％）患者ERCP后出现轻度急性胰腺炎。19例（95％）患者肝癌无原位复发，1例（5％）局部复发再行消融后病灶完全坏死。结论近肝门部肝癌根治性微波消融中，经ENBD灌注冷却液是防止胆管热损伤安全、有效的方法。 Objective To evaluate the effectiveness of ENBD tube intraductal cooling technique in preventing bile thermal injury complications caused by percutaneous microwave ablation（PMWA） for hepatocellular carcinomas adjacent to central bile duct. Methods Between September 2013 and May 2015, 20 consecutive patients with hepatoeellular carcinomas were enrolled in this prospective study. The 20 nodules were close to major bile ducts. An ENBD tube in the hepatic duct was first placed close to the lesion, then 4℃ chilled saline solution was infused via the ENBD tube to prevent heat damage during PMWA. Biliary complications and local tumor recurrence were evaluated after the operation. Results The average follow-up was 8.0 months. There were no ENBD-related or PMWA-related mortality. Bile duct complications did not happen in 19 cases （95%）,and 1 case （5%） presented biloma. Two cases （10%） suffered hemorrhage after incised vater papilla, 3 cases （15%） suffered acute pancreatitis. Nineteen cases （95%） had no local recurrence of hepatocellular carcinoma, and complete necrosis occurred in 1 case （5%） with local recurrence tumor after second PMWA. Conclusion Cooling of bile ducts via an ENBD tube is a safe and effective measure to prevent bile duct injury by PMWA of HCC close to major bile ducts.

作者葛乃建黄剑杨业发申淑群伍路朱俊军张一军刘学高道键吴孟超

机构地区第二军医大学东方肝胆外科医院微创介入中心第二军医大学东方肝胆外科医院内镜科第二军医大学东方肝胆外科医院肝外一科

出处《中华消化内镜杂志》北大核心 2016年第5期277-281,共5页 Chinese Journal of Digestive Endoscopy

基金上海市市级医院新兴前沿技术联合攻关项目（SHDC12014112）

关键词肝肿瘤微波消融胆道并发症胆道冷却技术经内镜鼻胆管引流术 Liver neoplasms Microwave ablation Biliary complications Bile duct cooling technique Endoscopic nasobiliaIy drainage

分类号 R735.7 [医药卫生—肿瘤]

引文网络
相关文献

参考文献15

1Page AJ, Cosgrove DC, Philosophe B, et al. Hepatocellular car- cinoma: diagnosis, management, and prognosis [ J ]. Surg Oncol Clin N Am, 2014, 23 ( 2 ) : 289-311. DOI: 10. 1016/j. soc.2013. 10. 006.
2Tabrizian P, Roayaie S, Schwartz ME. CmTent management of hepatocellular carcinoma [ J ]. World J Gastroenterol, 2014, 20 (30) : 10223-10237. DOI: 10. 3748/wjg.v20.i30. 10223.
3EASL-EORTC clinical practice guidelines: management of hepa- tocellular carcinoma [ J ]. J Hepatol, 2012, 56 (4) : 908-943. DOI: 10. 1016/j.jhep.2011. 12. 001.
4Seror O. Percutaneous hepatic ablation: what needs to be known in 2014[ J]. Diagn Interv Imaging, 2014, 95 (7-8) : 665-675. DOI: 10. 1016/j.diii.2014. 04. 002.
5Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma[ J]. Oncology, 2007, 72 Suppl 1 : 124-131. DOI: 10. 1159/000111718.
6Ogawa T, Kawamoto H, Kobayashi Y, et al. Prevention of biliary complication in radiofrequency ablation for hepatocellular carcino- ma-Cooling effect by endoscopic nasobiliary drainage tube [ J ]. Eur J Radiol, 2010, 73 ( 2 ) : 385-390. DOI: 10. 1016/j. ejrad.2008.10. 021.
7原发性肝癌诊疗规范(2011年版)[J].临床肿瘤学杂志,2011,16(10):929-946. 被引量：988
8Mann CD, Metcalfe MS, Lloyd DM, et al. The safety and efficacy of ablative techniques adjacent to the hepatic vasculature and biliary system [ J ]. ANZ J Surg, 2010, 80 (1-2) : 41-49. DOI: 10. 1111/j.1445-2197. 2009. 05174.x.
9Groeschl RT, Pilgrim CH, Hanna EM, et al. Microwave ablation for hepatic malignancies : a multiinstitutional analysis [ J ]. Ann Surg, 2014,259(6) :1195-1200. DOI: 10. 1097/SLA..
10Ohnishi T, Yasuda I, Nishigaki Y, et al. Intraduetal chilled sa- line peffusion to prevent bile duct injury during percutaneous ra- diofrequency ablation for hepatoeellular carcinoma[ J]. J Gastro- enterol Hepatol, 2008,23(8 Pt 2) :e410-415. DOI: 10. llll/j. 1440-1746. 2007. 05091.x.